TARDBP and amyotrophic lateral sclerosis: Moreover, it remains to be investigated whether TDP‐43 phosphorylation influences the formation of amorphous, non‐amyloid TDP‐43 aggregates that have also been observed in ALS and FTD patient brains [9, 10].